Mirion Technologies, Inc. (MIR)
NYSE · Industrials · Specialty Industrial Machinery
$14.92+2.19%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $3.7B
- P/E (trailing)
- 165.8
- Forward P/E
- 22.1
- 52-week range
- $14.04 – $30.28
- 52-week change
- −36.88%
- EPS (trailing)
- $0.09
- Analyst rating
- 1.4 Strong buy
- Next earnings
- Oct 27, 2026
Fiscal year to Dec 2025
- Revenue
- $925M (+7.50%)
- Net income
- $28.8M
- Operating margin
- 5.6%
- Diluted EPS
- $0.11
- Free cash flow
- $107M
From the company’s annual report on SEC EDGAR.
About Mirion Technologies, Inc.
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in North America, Europe, and the Asia Pacific. It operates in two segments, Medical, and Nuclear & Safety. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as product handling, medical imaging furniture, and rehabilitation products. This segment improves the quality and safety of cancer care delivery; and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools.
Headquarters: Atlanta, United States · 3,200 employees · mirion.com